Synapse Micro-current Ltd. is a leading medical technology based company specializing in developing and taking to market scientifically proven, clinically relevant medical devices.

Synapse was incorporated in January 2003 and in the early years focussed its efforts in defining IP rights, refining and securing patents and with subsequent product development. This work led in 2007, to Synapse achieving ISO 9001 Quality Management Systems & ISO 13485 accreditation for the design and manufacture of their micro-current devices for medical, veterinary and sports applications.

In addition, Synapse has several patents already granted and several pending in key territories of the world as well as a number of registered trademarks. Synapse’s medical devices have been designed to be prescribed by clinicians for specific medical conditions and self administered by the patient and as such are single program, treatment specific devices.

Presently Synapse is concentrating on:
1. Wound Management: Accel-Heal™ device - facilitating an accelerated rate of healing in all wounds focusing upon poorly and non-healing chronic and difficult to heal wounds.
2. Tendon (& Soft Tissue) Healing: Tendonworks™ device - the augmentation of the production of type 1 collagen to promote the regenerative sequence of normal tendon cyclical tissue turnover.

In 2009 independently conducted clinical trials on Chronic "non-healing" venous leg ulcers was completed. This study demonstrated that the Synapse Accel-Heal™ device made significant reductions in wound size, exudate levels and pain in a significant proportion of the trial patients.

In addition, Synapse produces two Sport devices that come up to the same high standard as the medical products.
1. Recovery - The accelerated repair of micro-damage muscle tissue post exercise.
2. Performance - Increases the energy potential of muscle cells by enhancing the levels of Adenosine Triphosphate (ATP). AMP-activated protein kinase (AMPK)

All Synapse products carry the CE marking. Synapse medical products are officially certified as Class IIA devices under the medical directive 93/42/EEC and have full Medical Devices Directive approval under ISO 13485:200 establishing safety and approval to launch in the European markets.

Currently, Synapse is currently going through the process of gaining FDA and TGA certification which will enable Synapse to sell their products in the USA and Australia respectively.

John Gildersleeve
Chief Executive
Co-founder of Synapse Micro-current Ltd.
As an Originator and Co-founder of the Tornado Group (Now World Television PLC), John was fully involved with all aspects of the business, including the initial funding and business plan, through to dealing with all the associated parties involved with a public floatation, raising £15m. Previously John was Head of the Music Division of Streets On Line Ltd where he was responsible for all aspects of Audiostreet.com and Labrador Records, In a short while, Audiostreet.com was both critically and commercially acclaimed, being at the time, the most successful music commerce site in Europe. Streets Online was subsequently acquired by the Kingfisher Group. John was also formerly a non executive director of face2face communications , overseeing the development of communication opportunities that now exist for corporate companies on the internet. Also overseeing the financial operations of the company saw the company enjoy record profits and growth of margin to a healthy 26% (Period end Dec 03)
Dr. David Chapman-Jones LLM (Med), FMS, MA (Ed), MSc, PhD
Director - Medicine & Science
Co-founder of Synapse Micro-current Ltd.
Trained at the Queens Medical Centre, Nottingham specialising in Sports and Exercise Medicine, Dr. Chapman-Jones focused on the clinical management of tendon pathology. This resulted in the research and development of a new treatment focussing upon accelerating tissue repair using micro-current technology. David has a wealth of clinical experience specialising in musculo-skeletal ultrasound and diagnostic soft-tissue imaging , working closely with SonoSite, the leaders in hand-held ultrasound units. This, in combination with the tendon research has led him to treat many top sportsmen and elite racehorses presenting with tendon problems.
In the years 1999/2000 David studied Forensic Medicine, Science and Law with the Worshipful Society of Apothecaries, Glasgow University and Guy's Hospital. This led him over the following five years to obtain an undergraduate Law degree and a Masters of Law in Medical Law and Medical Ethics. David is a member of the Inner Temple, Inns of Court and is interested in the subject area concerning the use of human tissue in medical and scientific research and the issue of informed consent in all medical procedures. Having successfully gained ethical approval previously for micro-current based research clinical trials this in-house knowledge is valuable for the company developing its portfolio of products.
John Parkinson
Chairman - Non Exec.
John has over thirty years of experience in commerce, property and professional sport. John brings to the Board a wealth of both public and private sector company knowledge along with an understanding of how businesses are run efficiently and profitably.
John has previously been involved with Higgs and Hill plc (now Hbg Ltd) Swan Hill plc and was formerly Chief Executive of Newcastle Falcons Rugby Ltd and Managing Director of Metnor Group PLC.
Martin Zapico
Non - Exec
Martin retired from his position as a Managing Director of Morgan Stanley after 20 years where he was the Global Head of the Securities Lending, Equity Swaps and Tax Arbitrage businesses. All of which were voted 'Best of Breed' among their peers. Martin is also a Director of the Westminster-based award winning Cinnamon Club restaurant.

Synapse medical products are officially certified as Class IIA devices under the medical directive 93/42/EEC.

click to download a (pdf) copy of the certification and declaration of conformity

Synapse products meet full Medical Devices Directive approval under the quality management system ISO 13485:2003.

Click here to download a (pdf) copy of the certification
All Synapse products carry the CE marking.

For a comprehensive document covering hazards, contra-indications and warranty please visit this link

The Synapse Micro-current Tendonworks™ and Accel-heal™ units are classified as class IIa medical devices, having been tested and approved by Notified Body 0120 at meeting the standards of the Medical Devices Directive and the ISO 13485 management system.